Anti-Estrogen Receptor alpha (phospho S118) 抗体 [E91]
Anti-Estrogen Receptor alpha (phospho S118) antibody [E91]
- RabMAb
- Recombinant
- Lab Essentials
- Advanced Validation
- 詳細を見る
4
(2 Reviews)
|
(26 Publications)
Rabbit Recombinant Monoclonal Estrogen Receptor alpha phospho S118 antibody. Suitable for Dot, WB, ICC/IF, ChIC/CUT&RUN-seq and reacts with Synthetic peptide, Human samples. Cited in 26 publications.
別名を表示する
ESR, NR3A1, ESR1, Estrogen receptor, ER, ER-alpha, Estradiol receptor, Nuclear receptor subfamily 3 group A member 1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma cell line) cells labeling Estrogen Receptor alpha (phospho S118) with unpurified ab32396 at 5 μg/ml (1/200 dilution). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. ab150077, an AlexaFluor®488 Goat anti-Rabbit was used as the secondary antibody at 2 μg/ml (1/1000 dilution). ab195889, Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain at 2.5 μg/ml (1/200 dilution). DAPI nuclear counterstain.
Confocal image showing the signal increased after EGF (100ng/ml, 5 min) treatment and decreased after Lambda Protein Phosphatase treatment (31°C for 2 hours).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma epithelial cell) treated with EGF (100ng/ml, 5min) and treated with Lambda Protein Phosphatase 31℃ for 2h cells labeling Estrogen receptor alpha (phospho S118) with purified ab32396 at 1 : 200 dilution (8.9μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
Immunofluorescent staining of (A) untreated and (B) Phosphatase-treated MCF-7 cells using unpurified ab32396.
- WB
Supplier Data
Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
All lanes:
Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (ab32396) at 1/1000 dilution
Lane 1:
MCF7 cell lysate (untreated)
Lane 2:
MCF7 cell lysate (treated with b-Estradiol and EGF)
Predicted band size: 66 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (ab32396) at 1/1000 dilution
Lane 1:
MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
MCF-7 (Human breast adenocarcinoma epithelial cell) treated with epidermal growth factor whole cell lysates at 15 µg
Lane 3:
MCF-7 (Human breast adenocarcinoma epithelial cell) treated with epidermal growth factor whole cell lysates, then the membrane was incubated with phosphatase at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 66 kDa
Observed band size: 60 kDa
false
Exposure time: 5s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- Dot
Unknown
Dot Blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
Dot blot analysis of Lane 1 : Estrogen Receptor alpha (pS118) phospho peptide and Lane 2 : Estrogen Receptor alpha non-phospho peptide labeling Estrogen Receptor alpha (phospho S118) with unpurified ab32396 at 1/1000 dilution. 5% NFDM/TBST was used as the diluting and blocking buffer. ab97051, Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated was used as the secondary antibody at 1/100000 dilution. Exposure time : 3 minutes.
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERα plays a significant role in the regulation of estrogen signaling. Estrogens binding to ERα activate the receptor which can form a homodimer or heterodimer complex with other proteins like coactivators or corepressors. This complex then modulates the transcription of genes involved in cell growth proliferation and differentiation. ERα is closely linked with processes like reproductive tissue development and maintenance.
Pathways
ERα is involved in the estrogen signaling pathway and the cell cycle regulation pathway. In the estrogen signaling pathway ERα works together with proteins such as coactivators which enhance gene transcription and corepressors which can inhibit transcription. In the context of cell cycle regulation ERα's interactions with other cell cycle proteins help control cell division and proliferation linking ERα activity to the progression through different stages of the cell cycle.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (26)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 11:451 PubMed41057309
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 43:173 PubMed38898487
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biology 12: PubMed37998017
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302561 PubMed37897317
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 29:866-877 PubMed36269797
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 50:10230-10248 PubMed36124682
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 42:7969-7983 PubMed36261268
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biology 42:e0019122 PubMed36036613
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular metabolism 45:101149 PubMed33352311
2020
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:15991-16002 PubMed33067917
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com